Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antikörperseroprävalenz Und Hintergrundinfektionsrate Von SARS-CoV-2 in Einem österreichischen Schlüsselkollektiv an Arbeitnehmer*Innen

NCT04354779 is registered in ClinicalTrials.gov with AUVA as lead sponsor.

NCT NCT04354779
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04354779 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antikörperseroprävalenz Und Hintergrundinfektionsrate Von SARS-CoV-2 in Einem österreichischen Schlüsselkollektiv an Arbeitnehmer*Innen
Lead sponsor
AUVA
Phase
Observational
Overall status
Completed
Start date
May 11, 2020
Completion date
September 28, 2020
Enrollment
3,301 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus infection, covid19, sars-cov 2, severe acute respiratory syndrome coronavirus 2